Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity
JAMA · 2023
DOI: 10.1001/jama.2023.10825 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Kristyn Brandi und 2 weiteren Autor:innen. Beteiligte Einrichtung: American College of Obstetricians and Gynecologists, Washington, DC. Hauptthemen laut MEDLINE: Contraceptives, Oral, Health Services Accessibility, Nonprescription Drugs, Health Equity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint argues that making a progestin-only contraceptive pill available for sale as an over-the-counter product will help reduce logistic barriers to safe and effective birth control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- American College of Obstetricians and Gynecologists, Washington, DC.
- Department of Pediatrics, George Washington School of Medicine, Washington, DC.
- Departments of Obstetrics and Gynecology and Reproductive Biology, University Hospitals Medical Center and Case Western Reserve University, Cleveland, Ohio.
Zitieren
APA
Brandi, K., Upadhya, K. K., & Teal, S. B. (2023). Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity. JAMA. https://doi.org/10.1001/jama.2023.10825
Vancouver
Brandi K, Upadhya KK, Teal SB. Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity. JAMA. 2023. doi:10.1001/jama.2023.10825
BibTeX
@article{Brandi2023,
author = {Brandi, Kristyn and Upadhya, Krishna K and Teal, Stephanie B},
title = {Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.10825}
}
EUVIMED